1,595
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Untargeted metabolomics profiling in a mouse model of lung cancer treated with thermal ablation

, , , , , , & show all
Pages 11258-11268 | Received 27 Nov 2021, Accepted 06 Apr 2022, Published online: 28 Apr 2022

References

  • NCCN guidelines: non-small cell lung cancer (Version 5.2021). accessed on 2021 Aug 13. Available online: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
  • Erinjeri JP, Clark TWI. Cryoablation: mechanism of action and devices. Jvir. 2010;21:S187–S191.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nature rev Cancer. 2014;14:199–208.
  • Katzman D, Wu S, Sterman DH. Immunological aspects of cryoablation of non-small cell lung cancer: a comprehensive review. J Thorac Oncol. 2018;13:624–635.
  • Takahashi Y, Izumi Y, Matsutani N, et al. Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer. Cancer Immunol Immunother. 2016;65(8):973–982.
  • Schneider T, Sevko A, Heussel CP, et al. Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer. Clin Exp Immunol. 2015;180(3):467–474.
  • Noreldeen HAA, Liu X, Xu G. Metabolomics of lung cancer: analytical platforms and their applications. J Sep Sci. 2020;43:120–133.
  • Hao D, Sengupta A, Ding K, et al. Metabolites as prognostic markers for metastatic non-small cell lung cancer (NSCLC) patients treated with first-line platinum-doublet chemotherapy. Cancers (Basel). 2020;12(7):1926.
  • Miller HA, Yin X, Smith SA, et al. Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data. Lung Cancer. 2021;156:20–30.
  • Hu T, An Z, Sun Y, et al. Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: phenotype, Efficacy, and Toxicity. Front Oncol. 2020;10:548300.
  • Sun Z-Q, Yang Y, Liu J. Alternative cooling and heating as a novel minimally invasive approach for treating obesity. Int J Ther Sci. 2013;64:29–39.
  • Yan J-F, Deng Z-S, Liu J, et al. New modality for maximizing cryosurgical killing scope while minimizing mechanical incision trauma using combined freezing-heating system. J Med Devices. 2007;1(4):264–271.
  • Zhou T, Chen YJ, Li LY, et al. Non-extended cryoablation could be a new strategy in lung cancer management: an experiment on green fluorescent protein-labeled Lewis lung cancer-bearing mice. Cryobiology. 2015;71(1):40–46.
  • Yang W, An Y, Li Q, et al. Co-ablation versus cryoablation for the treatment of stage III-IV non-small cell lung cancer: a prospective, noninferiority, randomized, controlled trial (RCT. Thorac Cancer. 2020;475–483. DOI:10.1111/1759-7714.13779
  • Sun Z, Shen K, Xie Y, et al. Shiquan Yuzhen Decoction inhibits angiogenesis and tumor apoptosis caused by non-small cell lung cancer and promotes immune response. Am J Transl Res. 2021;13:7492–7507.
  • Zhou T, Li QW, Chi XY, et al. 0 degrees C is better?- Thawing temperature optimization study for cancer cryoablation in a mouse model with green fluorescent protein-labeled Lewis lung cancer. Cryobiology. 2017;75:80–87.
  • Chen H-M, van der Touw W, Wang YS, et al. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity. J Clin Invest. 2018;128(12):5647–5662.
  • Want EJ, Masson P, Michopoulos F, et al. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc. 2013;8:17–32.
  • Want EJ, Wilson ID, Gika H, et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc. 2010;5:1005–1018.
  • Dunn WB, Broadhurst D, Begley P, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060–1083.
  • Wen B, Mei Z, Zeng C, et al. metaX: a flexible and comprehensive software for processing metabolomics data. BMC Bioinformatics. 2017;18(1):183.
  • Rao G, Sui J, Zhang J. Metabolomics reveals significant variations in metabolites and correlations regarding the maturation of walnuts (Juglans regia L. Biol Open. 2016;5:829–836.
  • de Baere T, Tselikas L, Woodrum D, et al. Evaluating cryoablation of metastatic lung tumors in patients–safety and efficacy: the ECLIPSE trial–interim analysis at 1 year. J Thorac Oncol. 2015;10:1468–1474.
  • Cheng M, Fay M, Steinke K. Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: a retrospective study. Int J Hyperthermia. 2016;32(3):316–323.
  • Kulkarni A, Nadler JL, Mirmira RG, et al. Regulation of Tissue Inflammation by 12-Lipoxygenases. Biomolecules. 2021;11(5):717.
  • Steimle A, Autenrieth IB, Frick J-S. Structure and function: lipid A modifications in commensals and pathogens. Int J Med Microbiol. 2016;306(5):290–301.
  • Ghyselinck NB, Duester G. Retinoic acid signaling pathways. Development. 2019;146(13):dev167502.
  • Anderson G. Tumour microenvironment: roles of the aryl hydrocarbon receptor, O-GlcNAcylation, Acetyl-CoA and melatonergic pathway in regulating dynamic metabolic interactions across cell types-tumour microenvironment and metabolism. Int J Mol Sci. 2020;22:141.
  • Chakraborty S, Pramanik J, Mahata B. Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies. Genes Immun. 2021;22(3):125–140.
  • Asavasupreechar T, Chan MSM, Saito R, et al. Sex steroid metabolism and actions in non-small cell lung carcinoma. J Steroid Biochem Mol Biol. 2019;193:105440.
  • Mohan AA, Tomaszewski WH, Haskell-Mendoza AP, et al. Targeting Immunometabolism in Glioblastoma. Front Oncol. 2021;11:696402.
  • Golshani-Hebroni SG, Bessman SP. Hexokinase binding to mitochondria: a basis for proliferative energy metabolism. J Bioenerg Biomembr. 1997;29(4):331–338.
  • Razak MA, Begum PS, Viswanath B, et al. Multifarious beneficial effect of nonessential amino acidv. Oxid Med Cell Longev. 2017;2017:1716701.
  • Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21(3):297–308.
  • Chen M, Zhang W, Wu H, et al. Mannitol: physiological functionalities, determination methods, biotechnological production, and applications. Appl Microbiol Biotechnol. 2020;104(16):6941–6951.
  • Wang M, Wang D, Chen Q, et al. Recent advances in glucose-oxidase-based nanocomposites for tumor therapy. Small (Weinheim an der Bergstrasse Germany). 2019;15:e1903895.
  • Tantawy MA, Nafie MS, Elmegeed GA, et al. Auspicious role of the steroidal heterocyclic derivatives as a platform for anti-cancer drugs. Bioorg Chem. 2017;73:128–146.
  • Lee S-B, Lee S, Park J-Y, et al. Induction of p53-Dependent Apoptosis by Prostaglandin A. Biomolecules. 2020;10(3):492. 10.3390/biom10030492.
  • Kim D-H, Kim E-H, Na H-K, et al. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells. Ann N Y Acad Sci. 2009;1171:202–209.
  • Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells. 2021;10(5):1056.
  • Sonkar K, Ayyappan V, Tressler CM, et al. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. NMR Biomed. 2019;32(10):e4112.
  • Pang J-S, Wen D-Y, He R-Q, et al. Incomplete thermal ablation-induced up-regulation of transcription factor nuclear receptor subfamily 2, group F, member 6 (NR2F6) contributes to the rapid progression of residual liver tumor in hepatoblastoma. Bioengineered. 2021;12(1):4289–4303.